Company: AEMD
Filing Date: 2025-02-12
Form Type: 10-Q
Source: 0001683168-25-000960
Chunk: 21

Company: AETHLON MEDICAL INC
Filing Date: 2025-02-12
Form: 10-Q
Item: Item 1
Chunk 21
---
  
    Weighted Average Grant Date Fair Value 
  
    Nonvested stock options at April 1, 2024 
     28,653  
    $1.44 
  
    Vested 
     (11,172) 
    $1.67 
  
    Forfeited 
     (9,588) 
    $1.19 
  
    Nonvested stock options at December 31, 2024 
     7,893  

     16 

The detail of the options outstanding and exercisable as of December
31, 2024 is as follows:

    Schedule of options outstanding and exercisable  

    Options Outstanding  
    Options Exercisable 
  
    Exercise Prices  
    Number  Outstanding  
    Weighted  Average  Remaining  Life (Years)  
    Weighted  Average  Exercise  Price  
    Number  Outstanding  
    Weighted  Average  Exercise  Price 
  
    $12.80 - 16.80  
     46,730  
     5.57 years  
    $13.71  
     39,089  
    $13.63 
  
    $25.20  
     23,170  
     3.14 years  
    $25.20  
     22,918  
    $25.20 

     69,900  

     62,007  

The table below summarizes RSUs as of December
31, 2024 and changes during the nine months ended December 31, 2024.

    Schedule of RSUs 

    Shares 
  
    Nonvested RSUs at April 1, 2024 
     4,885 
  
    Granted 
     131,576 
  
    Vested 
     (76,943)
  
    Tax withholding payments or tax equivalent payments for net share settlement of RSUs 
     (26,624)
  
    Nonvested RSUs at December 31, 2024 
     32,894 

Our total stock-based compensation for the three
and nine months ended December 31, 2024 and 2023 included the following:

    Schedule of stock-based compensation 

    Three Months Ended  
    Nine Months Ended 

    December 31, 2024  
    December 31, 2023  
    December 31